Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
Total
Public Offering
Private Placement
Equity Line Of Credit
Preferred Stock
Preferred Stock
Public Offering
Common Stock
Common Stock
Public Offering
Common Stock
Private Placement
Common Stock
Equity Line Of Credit
Additional Paid-In Capital
Additional Paid-In Capital
Public Offering
Additional Paid-In Capital
Private Placement
Additional Paid-In Capital
Equity Line Of Credit
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2022         7   199,608                  
Beginning balance at Dec. 31, 2022 $ 11,407,600       $ 0   $ 17,986       $ 146,035,314       $ (134,462,959) $ (182,741)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock-Based Compensation 307,736                   307,736          
Issuance of common stock (in shares)           3,908   244,181 5,866 13,889            
Issuance of Common Stock   $ 5,595,962 $ 115,715 $ 442,310   $ 39   $ 21,976 $ 528 $ 1,250   $ 5,573,947 $ 115,187 $ 441,060    
Conversion of Preferred Stock into Common Stock (in shares)         (2,958)   298,758                  
Conversion of Preferred Stock into Common Stock 0       $ (29)   $ 26,889       (26,859)          
Issuance of Common Stock from Warrant Exercises (in shares)             5,556                  
Issuance of Common Stock from Warrant Exercises 298,500           $ 500       298,000          
Unrealized Loss in Marketable Securities 0                              
Foreign Currency Translation Adjustment (43,120)                             (43,120)
Net Income (Loss) (4,482,349)                           (4,482,349)  
Ending balance (in shares) at Jun. 30, 2023         957   767,858                  
Ending balance at Jun. 30, 2023 13,642,355       $ 10   $ 69,129       152,744,385       (138,945,308) (225,861)
Beginning balance (in shares) at Mar. 31, 2023         7   213,252                  
Beginning balance at Mar. 31, 2023 10,155,509       $ 0   $ 19,214       146,683,202       (136,331,495) (215,412)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock-Based Compensation 171,795                   171,795          
Issuance of common stock (in shares)           3,908   244,181   11,667            
Issuance of Common Stock   $ 5,595,962   $ 343,350   $ 39   $ 21,976   $ 1,050   $ 5,573,947   $ 342,300    
Conversion of Preferred Stock into Common Stock (in shares)         (2,958)   298,758                  
Conversion of Preferred Stock into Common Stock 0       $ (29)   $ 26,889       (26,859)          
Unrealized Loss in Marketable Securities 0                              
Foreign Currency Translation Adjustment (10,449)                             (10,449)
Net Income (Loss) (2,613,813)                           (2,613,813)  
Ending balance (in shares) at Jun. 30, 2023         957   767,858                  
Ending balance at Jun. 30, 2023 13,642,355       $ 10   $ 69,129       152,744,385       (138,945,308) (225,861)
Beginning balance (in shares) at Dec. 31, 2023         427   856,182                  
Beginning balance at Dec. 31, 2023 6,109,654       $ 4   $ 77,078       153,192,228       (146,976,855) (182,801)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock-Based Compensation 325,238                   325,238          
Issuance of common stock (in shares)             1,755,556                  
Issuance of Common Stock 13,808,815           $ 158,000       13,650,815          
Issuance of Common Stock from Warrant Exercises (in shares)             358,831                  
Issuance of Common Stock from Warrant Exercises 1,689,339           $ 32,295       1,657,044          
Adjustments Due to the Rounding Impact from the Reverse Stock Split for Fractional Shares (in shares)             (24)                  
Unrealized Loss in Marketable Securities (2,828)                             (2,828)
Foreign Currency Translation Adjustment (60,106)                             (60,106)
Net Income (Loss) 11,231,561                           11,231,561  
Ending balance (in shares) at Jun. 30, 2024         427   2,970,545                  
Ending balance at Jun. 30, 2024 33,101,673       $ 4   $ 267,373       168,825,325       (135,745,294) (245,735)
Beginning balance (in shares) at Mar. 31, 2024         427   2,917,355                  
Beginning balance at Mar. 31, 2024 34,904,363       $ 4   $ 262,584       168,429,797       (133,523,648) (264,374)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Stock-Based Compensation 149,795                   149,795          
Issuance of Common Stock from Warrant Exercises (in shares)             53,213                  
Issuance of Common Stock from Warrant Exercises 250,522           $ 4,789       245,733          
Adjustments Due to the Rounding Impact from the Reverse Stock Split for Fractional Shares (in shares)             (23)                  
Unrealized Loss in Marketable Securities (2,828)                             (2,828)
Foreign Currency Translation Adjustment 21,467                             21,467
Net Income (Loss) (2,221,646)                           (2,221,646)  
Ending balance (in shares) at Jun. 30, 2024         427   2,970,545                  
Ending balance at Jun. 30, 2024 $ 33,101,673       $ 4   $ 267,373       $ 168,825,325       $ (135,745,294) $ (245,735)